Reduced NOX2 activity has been correlated with increased survival in ALS patients (Marrali et al., 2014) and NOX2 expression was reported to be increased in symptomatic mSOD1 microglia (Chiu et al., 2013). Here, CYBB is linked to amyotrophic lateral sclerosis.